Comments to FDA: Determining Whether Human Research Studies Can Be Conducted Without an IND

Share page:

Comments | Apr 7, 2014

Docket Number:

Comments regarding guidance for clinical investigators, sponsors, and institutional review boards on investigational new drug applications—Determining whether human research studies can be conducted without an investigational new drug application.

Related Posts

Press Releases and Statements

CHPA Welcomes Three Consumer Healthcare Industry Members

Press Releases and Statements

CHPA Statement: OTC Pain Relievers and COVID-19 Vaccines